NCT00186095撤回不适用
Mixed Chimeric Transplantation for Primary Amyloidosis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 主要终点
- Treatment of patients with nonmyeloablative allogeneic transplant for amyloidosis.
研究概览
简要总结
To evaluate the role of nonmyeloablative allogeneic transplantation in Amyloidosis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- — 至 60 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •primary amyloidosis
- •adequate organ function
- •matched sibling donor
排除标准
- •evidence of multiple myeloma
- •HIV positive
结局指标
主要结局
Treatment of patients with nonmyeloablative allogeneic transplant for amyloidosis.
次要结局
- Toxicity of therapy
- Changes in marrow and serum abnormalities
- Improvement in end-organ function.
研究者
相似试验
已完成
2 期
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple MyelomaBlood CancerMultiple MyelomaNCT00185614Wen-Kai Weng63
已完成
不适用
Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple MyelomaMultiple MyelomaNCT00185653Stanford University40
Unknown
2 期
Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)Multiple MyelomaNCT00702247Azienda Ospedaliera San Giovanni Battista
已完成
2 期
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell LymphomaMycosesSezary SyndromeLymphoma, T-Cell, CutaneousBone Marrow Transplant FailureLymphoma, Non-HodgkinCutaneous T-cell LymphomaNCT00896493Stanford University38
已完成
不适用
Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell TransplantationAmyloidosisNCT01606280Mayo Clinic400